According to the Pharmaceutical Manufacturers Association of Turkey, the Turkish prescription medications market had reached 9.1 billion USD in value and 1.42 billion in volume in 2009,representing 16.8% and 3.9% growth respectively and making Turkey the fastest growing market in the Mediterranean.

The Turkish pharmaceutical market is rather advanced in terms of  manufacturing standards,technology and production capacity and capabilities.

Pharmaceutical companies are not only continuously audited according to the stringent  Ministry of Health criteria but also are accredited by international authorities.GMP (Good Manufactoring Standards) are standards set by World Health Organization covering the entire process of medication production and control and they were incorporated into legal rules and regulations in Turkey in 1984.Turkey is among the few countries in the world that are self-sufficient in terms of pharmaceutical supply and it ranks 16th among the world's 35 leading pharmaceutical producing countries.There are 43 manufacturing plants in the country-14 of which are owned by multi-national companies,representing over 300 billion USD worth of foreign direct investment.Some of these multi-national companies are giants such as Pfizer, Novartis, Eli Lilly, Merck and GlaxoSmithKlein.

Turkey has a strong generics industry, about half of the market in terms of volume is generics drugs.Of the 7,413 medications available in the country in 2009,over 60%(and 78% of the volume consumed)were domestically produced.Widespread use of generics and local production capabilities both contribute to the lower costs of heatlhcare in Turkey.